Recent Company News

• 07:17 AM ET Aug 19, 2025
  

  StreetAccount Metrics Recap - Wuxi Biologics (Cayman) H1 Earnings (HK$29.78, 0.00)

• 07:09 AM ET Aug 19, 2025
  

  Wuxi Biologics (Cayman) reports H1 adjusted net income CNY2.39B, +6% vs year-ago CNY2.25B (HK$29.78, 0.00)

• 10:51 AM ET Aug 07, 2025
  

  Wuxi Biologics (Cayman) upgraded to buy from neutral at UBS (HK$30.02, 0.00)

• 05:48 AM ET Aug 01, 2025
  

  StreetAccount Sector Summary - China Healthcare July Recap

• 03:46 AM ET Jul 30, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (44 total)

• 03:29 AM ET Jul 29, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (39 total)

• 08:41 PM ET Jul 27, 2025
  

  Wuxi Biologics (Cayman) upgraded to buy from neutral at Zhongtai International (25-Jul, timing uncertain) (HK$31.50, 0.00)

• 05:07 AM ET Jul 27, 2025
  

  Wuxi Biologics (Cayman) upgraded to outperform from neutral at Macquarie (HK$31.50, 0.00)

• 04:00 AM ET Jul 25, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (31 total)

• 11:45 PM ET Jul 24, 2025
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning